Vion (formerly Oncorx) interesting play on Gene Therapy Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Vion (formerly Oncorx) interesting play on Gene Therapy

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Jim Oravetz who wrote (339)	5/23/2007 12:57:04 PM
From: Jim Oravetz	Read Replies (1) of 370

OUCH:Vion Suspends Phase III Trial Of Drug For Relapsed AML >VION DOW JONES NEWSWIRES May 23, 2007 8:09 a.m. Vion Pharmaceuticals Inc. (VION) suspended the Phase III trial of its Cloretazine drug for patients with relapsed adult myelogenous leukemia, pending a detailed review of data from the trial. The New Haven, Conn., biopharmaceutical company said a review of interim data by the trial's independent data safety monitoring board found that any advantage in complete remission could be compromised by the observed on-study mortality to date. Vion said data from the trial, which included 210 patients, will remain blinded while a complete medical review is conducted.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next